US EditionPublished • loading... • Updated
WuXi Biologics Selected as Constituent of FTSE4Good Index Series for Fifth Consecutive Year
- WuXi Biologics has been selected as a constituent of the FTSE4Good Index Series for the fifth consecutive year, as announced by the company.
- The FTSE4Good Index Series measures companies with strong Environmental, Social, and Governance practices, according to FTSE Russell.
- WuXi Biologics has shown outstanding performance in corporate governance, anti-corruption, labor standards, and water security, according to FTSE Russell ESG ratings.
- The company's selection reflects its commitment to sustainability, which WuXi Biologics considers essential for long-term growth.
Insights by Ground AI
80 Articles
80 Articles
Bennington Banner+78 Reposted by 78 other sources
WuXi Biologics Selected as Constituent of FTSE4Good Index Series for Fifth Consecutive Year
SHANGHAI, Sept. 23, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been selected as a constituent company of the FTSE4Good Index Series, marking the fifth consecutive year the…
WuXi Biologics Named to FTSE4Good Index Series for Fifth Consecutive Year
WuXi Biologics has been named a constituent of the FTSE […] The post WuXi Biologics Named to FTSE4Good Index Series for Fifth Consecutive Year first appeared on GeneOnline News. The post WuXi Biologics Named to FTSE4Good Index Series for Fifth Consecutive Year appeared first on GeneOnline News.
Coverage Details
Total News Sources80
Leaning Left10Leaning Right4Center26Last UpdatedBias Distribution65% Center
Bias Distribution
- 65% of the sources are Center
65% Center
L 25%
C 65%
Factuality
To view factuality data please Upgrade to Premium
